Neurol. praxi. 2009;10(2):75-79

Depressive disorders in selected neurological affections

MUDr. Radovan Hrubý
Psychiatrická klinika MFN a UK JLF v Martine

Depressive disorder is one of the most frequently occuring mental disorders. The course of depression is often complicated by relapses,

recurrence, chronicity and subsyndromic manifestations. Depressive disorder occurs independently of other somatic or mental conditions.

Also, we distinguish so called organic or symptomatic depressive disorder accompanying many somatic disorders and being recognized as

the most common neuropsychiatric comorbidity. It often occurs in strokes, Alzheimer´s disease and other dementias, Parkinson´s disease,

epilepsy, multiple sclerosis and other neurological disorders. It is well known, clinical features of depressive disorder may markedly differ

from these in organic depression. Despite the progress of knowledge, pathogenesis of depression still remains not adequate understood.

It is conceptualized as a dysfunction of prefrontal cortex – amygdala/hippocampus – thalamus – basal ganglia circuit in terms of functional

neuroanatomy. The modern molecular research aims at disturbances of transnuclear signalization, transcriptional and nerve growth

factors and gene expression. Depression is a disorder with complex manifestations of emotivity, affectivity, motivation, cognition and

motoric, nerovegetative and endocrine functions. Because of very frequent occurence in neurological disorders, depression could be

considered as a prototype of neuropsychiatric disorder, which requires complex strategy in diagnostics, treatment and research.

Keywords: depression, neurological disorders, neuropsychiatry, organic.

Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrubý R. Depressive disorders in selected neurological affections. Neurol. praxi. 2009;10(2):75-79.
Download citation

References

  1. Cummings JL. Depression in Parkinson´s disease. Am J Psychiatry 1992; 149: 443-454. Go to original source... Go to PubMed...
  2. Cummings JL, Trimble MR. Neuropsychiatry and Behavioral Neurology, 2nd ed. Washington, London: American Psychiatric Publishing 2002; 35-55 a, 217-225 b.
  3. Duman RS, Henninger GR, Nestler EJ. A molecular and cellular theory of depresion. Arch Gen Psychiat 1997; 54: 597-606. Go to original source... Go to PubMed...
  4. Feinstein A. Multiple sclerosis and depression. In: The clinical neuropsychiatry of multiple sclerosis. Cambridge, UK: Cambridge University Press 1999; 26-50.
  5. Fišar Z, Jirák R. Vybrané kapitoly z biologické psychiatrie. Praha: Grada Publishing spol. s.r.o. 2001; 210-238.
  6. Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs 2002; 16: 291-302. Go to original source... Go to PubMed...
  7. Herman E, Hovorka J, Praško J, Jokl I, Ivančo A, Syrovátka J. Deprese u somaticky nemocných. Praha: Maxdorf 2002; 72-76.
  8. Holtzheimer III PE, Mayberg HS. Neuropsychiatric aspects of mood disorders. In: Yudofsky SC, Hales RE (eds.): Neuropsychiatry and behavioral neurosciences, 5th Edition. Washington, London: American Psychiatric Publishing, Inc 2008; 1003-1024.
  9. Hovorka J, Herman E. Neuropsychiatrické aspekty u epilepsie. Česká a Slovenská psychiatrie 2001; 97(3) - tématická príloha, 1-16.
  10. Höschl C. Poruchy nálady. In: Höschl C, Libiger J, Švestka J (eds.): Psychiatrie druhé, doplněné a opravené vydání. Praha: Tigis, spol. s.r.o. 2004; 420-465.
  11. Huff W, Steckel R, Sistzer M. Poststroke depression: Risk factors and effects on the course of the stroke. Nervenarzt 2003; 74: 104-114. Go to original source... Go to PubMed...
  12. Kanner AM. Depression in Neurological Disorders. Willingham: The Lundbeck Institute 2005; 7a, 68b, 103c, 36d.
  13. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602. Go to original source... Go to PubMed...
  14. Lee HB, Lyketsos CG. Depression in Alzheimer´s disease: heterogenity and related issues. Biol Psychiatry 2003; 54: 353-362. Go to original source... Go to PubMed...
  15. Levinson DF. The genetics of depression: a review. Biol Psychiatry 2006; 60: 84-92. Go to original source... Go to PubMed...
  16. Mayeux R, Stern Y, Williams JBW, Cote L, Frantz A, Dyrenfurth I. Clinical and biochemical features of depression in Parkinson´s disease. Am J Psychiatry 1986; 143: 756-759. Go to original source... Go to PubMed...
  17. Moore DP. Textbook of Clinical Neuropsychiatry. London: Arnold 2001; 254-284.
  18. Robinson RG, Bolduc P, Price TR. A two-year longitudinal study of post-stroke depression: diagnosis and outcome a tone and two year follow-up. Stroke 1987; 19: 837-843. Go to original source... Go to PubMed...
  19. Schiffer RB, Caine ED, Bamford KA, Levy S. Depressive episodes in patients with multiple sclerosis. Am J Psychiatry 1983; 140(11): 1498-1500. Go to original source... Go to PubMed...
  20. Schrag A, Jahanshahi M, Quinn NP. What contributes to depression in Parkinson´s disease? Psychol Med 2001; 31: 65-73. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.